Seed round closed; lead investor name and funding amount not disclosed in source. Continued support from existing partner Wyss Geneva. Company founded October 2024.
About Clee Medical
Swiss neurotechnology startup developing Neuro Access, an intraoperative real-time ultra-high-resolution brain imaging platform to improve precision in minimally invasive neurosurgery.
Geneva, Switzerland
Read Company ProfileFrequently Asked Questions
What type of funding round did Clee Medical raise?
Clee Medical raised a seed round.
Who invested in Clee Medical's seed?
The investors in Clee Medical's seed are: Unspecified Lead Investor, Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, Venture Kick, Wyss Geneva.
What type of investment was Clee Medical's seed?
Clee Medical's seed was a equity investment.
How will Clee Medical use the funds from its seed?
Clee Medical plans to use the funds for: expand development programs, expand clinical programs, advance toward first-in-human clinical study, accelerate clinical validation of Neuro Access.